BOLD
Price
$1.02
Change
-$0.05 (-4.67%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
23.95M
52 days until earnings call
DSGN
Price
$3.58
Change
-$0.24 (-6.28%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
216.86M
45 days until earnings call
Interact to see
Advertisement

BOLD vs DSGN

Header iconBOLD vs DSGN Comparison
Open Charts BOLD vs DSGNBanner chart's image
Boundless Bio
Price$1.02
Change-$0.05 (-4.67%)
Volume$7.7K
Capitalization23.95M
Design Therapeutics
Price$3.58
Change-$0.24 (-6.28%)
Volume$6.91K
Capitalization216.86M
BOLD vs DSGN Comparison Chart in %
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. DSGN commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and DSGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BOLD: $1.07 vs. DSGN: $3.82)
Brand notoriety: BOLD and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 259% vs. DSGN: 45%
Market capitalization -- BOLD: $23.95M vs. DSGN: $216.86M
BOLD [@Biotechnology] is valued at $23.95M. DSGN’s [@Biotechnology] market capitalization is $216.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLD is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 5 TA indicator(s) are bullish while DSGN’s TA Score has 4 bullish TA indicator(s).

  • BOLD’s TA Score: 5 bullish, 4 bearish.
  • DSGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BOLD is a better buy in the short-term than DSGN.

Price Growth

BOLD (@Biotechnology) experienced а +2.88% price change this week, while DSGN (@Biotechnology) price change was +0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

BOLD is expected to report earnings on Aug 18, 2025.

DSGN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($217M) has a higher market cap than BOLD($24M). DSGN YTD gains are higher at: -38.088 vs. BOLD (-63.103). DSGN has higher annual earnings (EBITDA): -67.79M vs. BOLD (-72.59M). DSGN has more cash in the bank: 230M vs. BOLD (138M). DSGN has less debt than BOLD: DSGN (2.14M) vs BOLD (48.6M). BOLD (0) and DSGN (0) have equivalent revenues.
BOLDDSGNBOLD / DSGN
Capitalization24M217M11%
EBITDA-72.59M-67.79M107%
Gain YTD-63.103-38.088166%
P/E Ratio0.14N/A-
Revenue00-
Total Cash138M230M60%
Total Debt48.6M2.14M2,270%
TECHNICAL ANALYSIS
Technical Analysis
BOLDDSGN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRIS2.220.05
+2.30%
Curis
NCDL16.590.29
+1.78%
Nuveen Churchill Direct Lending Corp
ANSS343.401.71
+0.50%
ANSYS
PRQR2.16N/A
N/A
ProQR Therapeutics NV
GPI433.52-8.44
-1.91%
Group 1 Automotive

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with XOMA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then XOMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
N/A
XOMA - BOLD
35%
Loosely correlated
-0.47%
DSGN - BOLD
34%
Loosely correlated
-3.29%
PRME - BOLD
33%
Poorly correlated
+9.50%
OVID - BOLD
33%
Poorly correlated
+9.06%
INBX - BOLD
33%
Poorly correlated
-0.80%
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-3.29%
VRDN - DSGN
48%
Loosely correlated
-1.02%
KRYS - DSGN
46%
Loosely correlated
+0.06%
IDYA - DSGN
46%
Loosely correlated
+1.27%
AURA - DSGN
46%
Loosely correlated
-4.26%
TRDA - DSGN
43%
Loosely correlated
-0.57%
More